InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,917.32
(
0.20%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bhp1rtp

Send PM Follow Ignore
Followers 7
Posts 317
Boards Moderated 0
Alias Born 12/08/2013

bhp1rtp

Re: leifsmith post# 21995

Friday, 01/30/2015 3:49:41 PM

Friday, January 30, 2015 3:49:41 PM

Post# of 30990
Yes I agree with your statement

"However, since the therapeutic effect to be measured is reduction of inflammation, and not the consequence of inflammation in any specific disease, it seems that more trials, targeting specific diseases, will be required before a product can be marketed.

The length of such trials, in many cases, might be short."



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up